nifedipine has been researched along with atosiban in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (41.67) | 29.6817 |
| 2010's | 17 (47.22) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Carbonne, B; Tsatsaris, V | 1 |
| Vayssière, C | 1 |
| Coomarasamy, A; Gee, H; Khan, KS; Knox, EM; Song, F | 1 |
| Beattie, RB; Helmer, H; Khan, KS; Lamont, RF; McNamara, H; Svare, J; Tsatsaris, V; van Geijn, HP | 1 |
| Rozenberg, P | 1 |
| Akbarian, AR; Kashanian, M; Soltanzadeh, M | 1 |
| Kim, A; Shim, JY | 1 |
| Bisits, A; Giles, W | 1 |
| Lamont, RF; Lyndrup, J | 1 |
| Kam, KY; Lamont, RF | 1 |
| Bazin, JE; Bolandard, F; Chanséaume, S; Constantin, JM; Gallot, D; Perbet, S; Vignaud, M; Zénut, M | 1 |
| Carlin, A; Cole, S; Norman, J; Smith, R | 1 |
| Jacquemyn, Y | 1 |
| de Heus, R; Derks, JB; Mulder, EJ; Visser, GH | 1 |
| Draycott, T; O'Brien, K; Siassakos, D | 1 |
| Khalil, A; Nassar, AH; Usta, IM | 1 |
| Chyczewski, L; Kowalczuk, O; Kuć, P; Laudański, P; Laudański, T | 1 |
| Baram, S; Garmi, G; Nachum, Z; Salim, R; Shalev, E; Zafran, N | 1 |
| Cheung, CS; Lee, CP; Li, TK | 1 |
| Al Kazaleh, FA; Al-Ramahi, MQ; Saleh, SS | 1 |
| Jørgensen, JS; Lamont, RF; Weile, LK | 1 |
| Boormans, EM; de Lange, TS; Mol, BW; Oudijk, MA; van Vliet, EO | 1 |
| Bax, CJ; Bijvank, BN; Bloemenkamp, KW; Duvekot, HJ; Franssen, MT; Franx, A; Gyselaers, W; Heida, KY; Jaquemyn, Y; Kok, JH; Kok, M; Mol, BW; Opmeer, BC; Oudijk, MA; Porath, MM; Scheepers, HC; Schuit, E; van Beek, E; van Vliet, EO; Woiski, M | 1 |
| Bax, CJ; Beek, EV; Bloemenkamp, KWM; Duvekot, JJ; Franssen, MTM; Franx, A; Gyselaers, W; Heida, KY; Jacquemyn, Y; Kok, JH; Kok, M; Mol, BW; Nijman, TAJ; Opmeer, BC; Oudijk, MA; Papatsonis, DN; Porath, MM; Scheepers, HCJ; Schuit, E; van der Post, JAM; van Vliet, EOG; Woiski, M | 1 |
| Jørgensen, JS; Lamont, CD; Lamont, RF | 1 |
| Benders, MJN; de Haan, TR; Franx, A; Goedhart, MM; Mol, BW; Naaktgeboren, CN; Nijman, TAJ; Oudijk, MA; Vijlbrief, DC | 1 |
| Bloemenkamp, K; de Boer, MA; Franx, A; Gyselaers, W; Kok, M; Mol, B; Nijman, T; Oudijk, MA; Porath, MM; Sueters, M; van Baaren, GJ; van Vliet, E; Woiski, M | 1 |
| Haas, DM | 1 |
| Abdel-Daim, MM; Ahmed, AMM; Ali, AA; Anwar, AT; El Sherif, L; Elgebaly, A; Loutfi, GO; Mohamed, HB; Sayed, AK; Taha, AS; Yahia, RM | 1 |
| Coates, S; Gotteland, JP; Lorch, U; Marchand, L; Pohl, O; Täubel, J | 1 |
| Hamburger, M; Haslinger, C; Mennet, M; Santos, S; Simões-Wüst, AP; von Mandach, U | 1 |
| Kleinrouweler, CE; Klumper, J; Mol, BW; Naaktgeboren, CA; Nijman, TA; Oudijk, MA; Pajkrt, E; Roos, C; Roseboom, TJ; Tichelaar, MA; van Baar, AL; van Wassenaer-Leemhuis, AG; van Winden, T; Van't Hooft, J | 1 |
| Thornton, JG | 1 |
| Al-Omari, WR; Kashanian, M; Kleinrouweler, CE; Mol, BW; Nijman, TAJ; Oudijk, MA; Pajkrt, E; Roos, C; Salim, R; van Winden, TMS | 1 |
| Boatwright, N; Crockett, SL; De, D; Hansen, CJ; Herington, JL; Newton, J; Paria, BC; Reese, J; Rogers, JH; Simpson, CL; Siricilla, S; Sulikowski, GA; Waterson, AG | 1 |
12 review(s) available for nifedipine and atosiban
| Article | Year |
|---|---|
[Which tocolytic drugs in case of preterm labor?].
Topics: Clinical Trials as Topic; Female; France; Humans; Nifedipine; Obstetric Labor, Premature; Practice Guidelines as Topic; Pregnancy; Ritodrine; Tocolytic Agents; Treatment Outcome; Vasotocin | 2002 |
[Special management for threatened preterm delivery in multiple pregnancies].
Topics: Adrenal Cortex Hormones; Drug Therapy, Combination; Female; France; Humans; Infant, Newborn; Nifedipine; Obstetric Labor, Premature; Practice Guidelines as Topic; Pregnancy; Pregnancy Outcome; Pregnancy, Multiple; Ritodrine; Tocolytic Agents; Ultrasonography, Prenatal; Vasotocin | 2002 |
Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.
Topics: Adrenergic beta-Agonists; Female; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic; Tocolysis; Tocolytic Agents; Treatment Outcome; Vasotocin | 2003 |
Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
Topics: Calcium Channel Blockers; Female; Humans; Nifedipine; Obstetric Labor, Premature; Oxytocin; Pregnancy; Tocolytic Agents; Vasotocin | 2006 |
Preterm labour. The present and future of tocolysis.
Topics: Adrenergic beta-Agonists; Female; Humans; Indomethacin; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Treatment Failure; Vasotocin | 2007 |
The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.
Topics: Adrenergic beta-Agonists; Antidiuretic Hormone Receptor Antagonists; Calcium Channel Blockers; Female; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Receptors, Oxytocin; Tocolytic Agents; Vasotocin | 2007 |
Developments in the pharmacotherapeutic management of spontaneous preterm labor.
Topics: Female; Fetus; Glucocorticoids; Health Care Costs; Humans; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents; Vasotocin | 2008 |
Oxytocin antagonists for the management of preterm birth: a review.
Topics: Female; Hormone Antagonists; Humans; Indoles; Nifedipine; Oligopeptides; Oxytocin; Premature Birth; Pyrrolidines; Sympathomimetics; Tocolytic Agents; Vasotocin | 2011 |
Preterm labor: current pharmacotherapy options for tocolysis.
Topics: Female; Humans; Infant, Newborn; Nifedipine; Obstetric Labor, Premature; Pregnancy; Premature Birth; Progesterone; Progestins; Tocolysis; Tocolytic Agents; Vasotocin | 2014 |
The safety of tocolytics used for the inhibition of preterm labour.
Topics: Animals; Female; Humans; Infant, Newborn; Nifedipine; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents; Vasotocin | 2016 |
Systematic review and meta-analysis of randomized controlled trials of atosiban versus nifedipine for inhibition of preterm labor.
Topics: Adult; Female; Humans; Nifedipine; Obstetric Labor, Premature; Odds Ratio; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents; Vasotocin | 2019 |
Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis.
Topics: Female; Humans; Infant, Newborn; Nifedipine; Perinatal Death; Pregnancy; Premature Birth; Systematic Reviews as Topic; Tocolysis; Tocolytic Agents; Vasotocin | 2022 |
10 trial(s) available for nifedipine and atosiban
| Article | Year |
|---|---|
Atosiban and nifedipin for the treatment of preterm labor.
Topics: Female; Humans; Nifedipine; Obstetric Labor, Premature; Oxytocics; Pregnancy; Tocolytic Agents; Vasotocin | 2005 |
The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow.
Topics: Adult; Algorithms; Betamethasone; Drug Combinations; Female; Fetal Blood; Fetal Movement; Heart Rate, Fetal; Humans; Infant, Newborn; Nifedipine; Placental Circulation; Pregnancy; Pregnancy Outcome; Premature Birth; Tocolytic Agents; Vasotocin | 2009 |
Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour.
Topics: Decision Trees; Female; Fibronectins; Health Services Research; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Vasotocin | 2009 |
Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial.
Topics: Adult; Cross-Over Studies; Female; Gestational Age; Humans; Infant, Newborn; Middle Aged; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Tocolytic Agents; Vasotocin; Young Adult | 2012 |
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
Topics: Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant Mortality; Infant, Newborn; Injections, Intravenous; Maternal Mortality; Netherlands; Nifedipine; Obstetric Labor, Premature; Outcome Assessment, Health Care; Pregnancy; Prognosis; Tocolysis; Tocolytic Agents; Vasotocin; Young Adult | 2014 |
Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
Topics: Administration, Intravenous; Administration, Ophthalmic; Adult; Belgium; Calcium Channel Blockers; Female; Humans; Infant, Newborn; Netherlands; Nifedipine; Perinatal Mortality; Pregnancy; Pregnancy Outcome; Premature Birth; Tocolytic Agents; Treatment Outcome; Vasotocin | 2016 |
Effect of nifedipine and atosiban on perinatal brain injury: secondary analysis of the APOSTEL-III trial.
Topics: Administration, Intravenous; Adult; Brain Injuries; Female; Gestational Age; Humans; Infant, Newborn; Male; Nifedipine; Pregnancy; Pregnancy Outcome; Premature Birth; Tocolytic Agents; Treatment Outcome; Vasotocin | 2018 |
Cost effectiveness of nifedipine compared with atosiban in the treatment of threatened preterm birth (APOSTEL III trial).
Topics: Cost-Benefit Analysis; Female; Humans; Nifedipine; Pregnancy; Pregnancy, Multiple; Premature Birth; Prenatal Care; Tocolytic Agents; Vasotocin | 2019 |
Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone.
Topics: Adolescent; Adult; Area Under Curve; Betamethasone; Cross-Over Studies; Drug Interactions; Esters; Female; Humans; Magnesium Sulfate; Middle Aged; Nifedipine; Receptors, Prostaglandin; Sulfones; Thiazolidines; Tocolytic Agents; Vasotocin; Young Adult | 2019 |
Effects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTEL III trial.
Topics: Child Behavior Disorders; Child, Preschool; Executive Function; Female; Follow-Up Studies; Health Status; Humans; Male; Neurodevelopmental Disorders; Nifedipine; Pregnancy; Premature Birth; Surveys and Questionnaires; Tocolysis; Tocolytic Agents; Vasotocin | 2020 |
14 other study(ies) available for nifedipine and atosiban
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Emerging issues over the choice of nifedipine, beta-agonists and atosiban for tocolysis in spontaneous preterm labour--a proposed systematic review by the International Preterm Labour Council.
Topics: Adrenergic beta-Agonists; Europe; Evidence-Based Medicine; Female; Humans; International Cooperation; Meta-Analysis as Topic; Nifedipine; Obstetric Labor, Premature; Practice Guidelines as Topic; Pregnancy; Systematic Reviews as Topic; Tocolytic Agents; United States; Vasotocin | 2004 |
[Licensed or non-licensed tocolysis?].
Topics: Female; Humans; Nifedipine; Pregnancy; Tocolysis; Tocolytic Agents; Vasotocin | 2005 |
[Non-invasive ventilation for pulmonary edema associated with tocolytic agents during labour for a twin pregnancy].
Topics: Adult; Apgar Score; Delivery, Obstetric; Female; Humans; Infant, Newborn; Nicardipine; Nifedipine; Pleural Effusion; Pregnancy; Pulmonary Edema; Respiration, Artificial; Tocolytic Agents; Tomography, X-Ray Computed; Twins; Vasotocin | 2008 |
Tocolytics and preterm labour.
Topics: Female; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Tocolytic Agents; Vasotocin | 2009 |
Adverse reactions to tocolytics. Atosiban v nifedipine.
Topics: Female; Humans; Nifedipine; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents; Vasotocin | 2009 |
Expression of selected genes in preterm premature rupture of fetal membranes.
Topics: Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Celecoxib; Cyclooxygenase 2 Inhibitors; Dinoprostone; Endometritis; Female; Fetal Membranes, Premature Rupture; Gene Expression Profiling; Gene Expression Regulation, Developmental; Humans; Nifedipine; Obstetric Labor, Premature; Oxytocics; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premature Birth; Pyrazoles; RNA, Messenger; Sulfonamides; Term Birth; Tocolytic Agents; Vasotocin | 2012 |
Maternal atrial fibrillation after sequential use of nifedipine and atosiban for treatment of preterm labor: case report.
Topics: Adult; Atrial Fibrillation; Drug Therapy, Combination; Female; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Cardiovascular; Tocolytic Agents; Vasotocin | 2013 |
Atosiban and nifedipine in the suppression of pre-term labour: a comparative study.
Topics: Adult; Female; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Retrospective Studies; Tocolytic Agents; Vasotocin; Young Adult | 2013 |
Preterm labor: current tocolytic options for the treatment of preterm labor.
Topics: Adrenergic beta-Agonists; Female; Glucocorticoids; Humans; Infant, Newborn; Nifedipine; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolysis; Tocolytic Agents; Vasotocin | 2014 |
The importance of cost considerations in preterm birth trials.
Topics: Cost-Benefit Analysis; Female; Humans; Infant, Newborn; Nifedipine; Pregnancy; Premature Birth; Vasotocin | 2019 |
Bryophyllum pinnatum enhances the inhibitory effect of atosiban and nifedipine on human myometrial contractility: an in vitro study.
Topics: Adult; Drug Antagonism; Female; Humans; In Vitro Techniques; Kalanchoe; Myometrium; Nifedipine; Plant Extracts; Pregnancy; Premature Birth; Tocolytic Agents; Uterine Contraction; Vasotocin; Young Adult | 2019 |
Different tocolytics appear equally safe long-term but we need both higher follow-up rates and placebo-controlled trials in future.
Topics: Child; Female; Follow-Up Studies; Humans; Nifedipine; Pregnancy; Tocolysis; Tocolytic Agents; Vasotocin | 2020 |
Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy.
Topics: Animals; Biological Products; Female; Humans; Infant, Newborn; Mice; Mifepristone; Nifedipine; Obstetric Labor, Premature; Premature Birth; Tocolytic Agents | 2023 |